MDK(SH:688079) Shang Hai Zheng Quan Bao·2026-01-05 19:19Core Viewpoint - The announcement details the implementation and results of the 2024 stock option and restricted stock incentive plan of Hangzhou Medike Technology Co., Ltd, highlighting the number of options exercised and the stock's circulation arrangements. Group 1: Stock Option Exercise Details - The first exercise period for the stock options under the 2024 incentive plan allows for the exercise of 3,506,280 options, with an actual exercise period from November 21, 2025, to November 17, 2026, and 2,270,926 shares have been exercised by December 31, 2025, accounting for 64.77% of the available options [2][10] - The stock acquired through the exercise will be credited to the accounts of the incentive participants on the first trading day after the exercise date (T+1) and will be available for trading on the second trading day (T+2) [3] Group 2: Approval and Implementation of the Incentive Plan - The stock option incentive plan was approved during the board meeting on September 27, 2024, and subsequently, the plan was publicly announced and no objections were raised during the internal disclosure period [4][5] - The number of incentive recipients was adjusted from 428 to 343, and the total number of stock options granted was reduced from 9,632,000 to 8,827,700 [6] Group 3: Changes in Shareholding and Financial Impact - The exercise of stock options resulted in an increase in total shares, leading to a dilution of the shareholding percentage of the controlling shareholder and its concerted parties [16] - The funds raised from the exercise, amounting to 16,736,724.62 yuan, will be used to supplement the company's working capital [16] - The exercise of options is not expected to have a significant impact on the company's financial status or operating results [17]